News release

JLL closes sale and financing of a purpose-built Chicagoland life sciences portfolio

JLL Capital Markets led the disposition and subsequent debt placement efforts of a two-building multi-tenant life sciences portfolio comprised of both wet lab and GMP facilities.

October 13, 2021

Kristen Murphy

Investor PR, Capital Markets, Hotels, Property Management
+1 617 848 1572

CHICAGO, Oct. 13, 2021 – JLL Capital Markets announced today that it has closed the sale and financing of 8045 and 8025 Lamon Ave., a two-building life sciences portfolio within The Illinois Science + Technology Park, located in Skokie, Illinois.

JLL marketed the property on behalf of the seller, American Landmark Properties, procured the buyer, Chicago-based Singerman Real Estate, and arranged the acquisition financing.  

Situated within the 22.6-acre master-planned Illinois Science + Technology Park, the portfolio consists of 286,184 rentable square feet contained within two adjacent buildings. The portfolio is comprised of a mix of highly technical wet lab and GMP space and is home to established global life sciences brands as well as prestigious university affiliated venture backed startups.  Situated within Chicago’s transit-oriented first ring suburbs, the portfolio benefits from a central location proximate to Chicago’s world-renowned universities, research institutions and deep labor pools.

American Landmark Properties is a private real estate investor specializing in value-add real estate opportunities. They originally acquired the 8025 and 8045 Lamon buildings in 2016 and quickly embarked on a renovation of the buildings. This allowed them to stabilize the park by adding a number of high-growth life science and biotech companies. The park has become a prosperous hub for innovation and discovery where businesses can grow and thrive.

The JLL Capital Markets team representing the seller was led by Sam DiFrancesca, Patrick Shields, Jaime Fink, Jeffrey Bramson, Bruce Miller and Nick Psyllos.

“We were encouraged by the depth of capital with an interest in Greater Chicago and are excited to see such an established national life sciences investor as Singerman committing to the market,” said DiFrancesca.

The JLL Capital Markets team leading financing efforts was led by Danny Kaufman and Lucas Borges.

“The lending community expressed a strong desire to place capital in Chicago’s emerging life sciences cluster,” Borges added. “The level of lender interest in this portfolio is further testament to Chicago’s significant growth potential within the life sciences space.”    

JLL agency leasing professionals Max Zwolan and Scott Brandwein also supported the transaction and will continue to handle the leasing for the buyers.

JLL Capital Markets is a full-service global provider of capital solutions for real estate investors and occupiers. The firm's in-depth local market and global investor knowledge delivers the best-in-class solutions for clients — whether investment sales and advisory, debt advisory, equity advisory or a recapitalization. The firm has more than 3,000 Capital Markets specialists worldwide with offices in nearly 50 countries.

For more news, videos and research resources on JLL, please visit our newsroom.

About JLL

JLL (NYSE: JLL) is a leading professional services firm that specializes in real estate and investment management. JLL shapes the future of real estate for a better world by using the most advanced technology to create rewarding opportunities, amazing spaces and sustainable real estate solutions for our clients, our people and our communities. JLL is a Fortune 500 company with annual revenue of $16.6 billion in 2020, operations in over 80 countries and a global workforce of more than 92,000 as of June 30, 2021. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit

About American Landmark

American Landmark Properties is a real estate investment group with a 35-year track record of delivering consistently strong returns to its investors. The company’s acquisition philosophy is to seek and acquire value-add and opportunistic mid-cap office, industrial and multifamily properties in the Midwest and East Coast.  Its skills and expertise include syndication, financing, leasing, sales and marketing, repositioning, renovation property/asset management and disposition.  For more information, please visit:

About Singerman Real Estate

Singerman Real Estate LLC (“SRE”) is an opportunistic real estate investment firm that has deep experience executing complex transactions and unlocking embedded value through the ownership of properties, real estate loans and operating companies. Since its formation in 2010, SRE has sourced and executed, with partners, over $3.2 billion in investments across all major property types. SRE has owned/developed nearly 2 million square feet of life science properties in Los Angeles, San Diego, Boston, San Francisco, Raleigh, and Washington DC.